NO20091662L - Nye antigener og antistoffer assosiert med pankreatisk, duktalt adenokarsinom - Google Patents
Nye antigener og antistoffer assosiert med pankreatisk, duktalt adenokarsinomInfo
- Publication number
- NO20091662L NO20091662L NO20091662A NO20091662A NO20091662L NO 20091662 L NO20091662 L NO 20091662L NO 20091662 A NO20091662 A NO 20091662A NO 20091662 A NO20091662 A NO 20091662A NO 20091662 L NO20091662 L NO 20091662L
- Authority
- NO
- Norway
- Prior art keywords
- pancreatic
- antibodies
- pda
- ductal adenocarcinoma
- identified
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 201000010985 invasive ductal carcinoma Diseases 0.000 title 1
- 201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 abstract 4
- 102000001708 Protein Isoforms Human genes 0.000 abstract 2
- 108010029485 Protein Isoforms Proteins 0.000 abstract 2
- 102000003839 Human Proteins Human genes 0.000 abstract 1
- 108090000144 Human Proteins Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 abstract 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06121552 | 2006-09-29 | ||
| EP06126726 | 2006-12-20 | ||
| PCT/EP2007/060305 WO2008037792A1 (en) | 2006-09-29 | 2007-09-28 | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091662L true NO20091662L (no) | 2009-06-29 |
Family
ID=38895810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091662A NO20091662L (no) | 2006-09-29 | 2009-04-27 | Nye antigener og antistoffer assosiert med pankreatisk, duktalt adenokarsinom |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8071721B2 (ru) |
| EP (1) | EP2069395B1 (ru) |
| JP (1) | JP2010505104A (ru) |
| KR (1) | KR20090094227A (ru) |
| CN (1) | CN101578295B (ru) |
| AT (1) | ATE542831T1 (ru) |
| AU (1) | AU2007301966B2 (ru) |
| BR (1) | BRPI0717282A2 (ru) |
| CA (1) | CA2664841A1 (ru) |
| DK (1) | DK2069395T3 (ru) |
| EA (1) | EA016731B1 (ru) |
| ES (1) | ES2381304T3 (ru) |
| IL (2) | IL197868A (ru) |
| NO (1) | NO20091662L (ru) |
| NZ (1) | NZ576409A (ru) |
| PL (1) | PL2069395T3 (ru) |
| PT (1) | PT2069395E (ru) |
| WO (1) | WO2008037792A1 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012500964A (ja) * | 2008-05-09 | 2012-01-12 | デューク ユニバーシティ | 癌の検出と治療における自己抗体 |
| IT1398782B1 (it) | 2009-09-11 | 2013-03-18 | Novelli | Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi. |
| ITTO20120523A1 (it) * | 2012-06-15 | 2013-12-16 | Natimab Therapeutics S R L | Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico |
| RU2656153C1 (ru) * | 2013-12-20 | 2018-05-31 | Девелопмент Сентер Фор Байотекнолоджи | Антитела, специфичные к альфа-энолазе, и способы применения в противоопухолевой терапии |
| CN106102835B (zh) | 2014-01-13 | 2020-11-03 | 博格有限责任公司 | 烯醇酶1(eno1)组合物及其用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753446A (en) * | 1993-04-15 | 1998-05-19 | National Jewish Center For Immunology & Respiratory Medicine | Mitogen ERK kinase kinase (MEKK) assay |
-
2007
- 2007-09-28 EP EP07820692A patent/EP2069395B1/en active Active
- 2007-09-28 CA CA002664841A patent/CA2664841A1/en not_active Abandoned
- 2007-09-28 AT AT07820692T patent/ATE542831T1/de active
- 2007-09-28 CN CN2007800423663A patent/CN101578295B/zh not_active Expired - Fee Related
- 2007-09-28 US US12/443,576 patent/US8071721B2/en not_active Expired - Fee Related
- 2007-09-28 PT PT07820692T patent/PT2069395E/pt unknown
- 2007-09-28 DK DK07820692.7T patent/DK2069395T3/da active
- 2007-09-28 KR KR1020097008777A patent/KR20090094227A/ko not_active Application Discontinuation
- 2007-09-28 EA EA200970332A patent/EA016731B1/ru not_active IP Right Cessation
- 2007-09-28 WO PCT/EP2007/060305 patent/WO2008037792A1/en active Application Filing
- 2007-09-28 ES ES07820692T patent/ES2381304T3/es active Active
- 2007-09-28 BR BRPI0717282-6A patent/BRPI0717282A2/pt not_active IP Right Cessation
- 2007-09-28 NZ NZ576409A patent/NZ576409A/en not_active IP Right Cessation
- 2007-09-28 JP JP2009529713A patent/JP2010505104A/ja active Pending
- 2007-09-28 AU AU2007301966A patent/AU2007301966B2/en not_active Ceased
- 2007-09-28 PL PL07820692T patent/PL2069395T3/pl unknown
-
2009
- 2009-03-26 IL IL197868A patent/IL197868A/en not_active IP Right Cessation
- 2009-04-27 NO NO20091662A patent/NO20091662L/no not_active Application Discontinuation
-
2012
- 2012-03-01 IL IL218442A patent/IL218442A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL197868A (en) | 2013-03-24 |
| JP2010505104A (ja) | 2010-02-18 |
| CA2664841A1 (en) | 2008-04-03 |
| CN101578295B (zh) | 2013-02-27 |
| EA200970332A1 (ru) | 2009-10-30 |
| BRPI0717282A2 (pt) | 2013-10-15 |
| WO2008037792A1 (en) | 2008-04-03 |
| IL218442A0 (en) | 2012-04-30 |
| US20100028907A1 (en) | 2010-02-04 |
| US8071721B2 (en) | 2011-12-06 |
| KR20090094227A (ko) | 2009-09-04 |
| AU2007301966A1 (en) | 2008-04-03 |
| CN101578295A (zh) | 2009-11-11 |
| IL197868A0 (en) | 2011-08-01 |
| DK2069395T3 (da) | 2012-05-14 |
| PT2069395E (pt) | 2012-04-27 |
| AU2007301966B2 (en) | 2013-02-21 |
| NZ576409A (en) | 2012-02-24 |
| EP2069395A1 (en) | 2009-06-17 |
| ATE542831T1 (de) | 2012-02-15 |
| EP2069395B1 (en) | 2012-01-25 |
| ES2381304T3 (es) | 2012-05-25 |
| EA016731B1 (ru) | 2012-07-30 |
| PL2069395T3 (pl) | 2012-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY162056A (en) | Diagnosis and treatment of cancer using anti -ereg antibody | |
| EP3885366A3 (en) | Therapeutic antibodies against ror-1 protein and methods for use of same | |
| MX2009013824A (es) | Proteinas de enlace de antigeno que enlazan par-2. | |
| CY1117236T1 (el) | Μονοκλωνικα αντισωματα εναντι γλυπικανης-3 | |
| PH12015500093A1 (en) | Il-17 binding proteins | |
| MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
| EA201000424A1 (ru) | Антитела к il-23 | |
| CY1119539T1 (el) | Πληρως ανθρωπινα αντισωματα ειδικα για to cadμ1 | |
| MY150400A (en) | Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof | |
| EP1996716A4 (en) | MANIPULATED ANTI-PROSTATE STEAM CELL RESPONSIVES (PSCA) ANTIBODIES FOR CANCER TARGETING | |
| BRPI0808940A8 (pt) | anticorpo humano ou fragmento de ligação do mesmo, antígeno, polinucleotídeo, vetor, célula hospedeira, método para preparar um anticorpo ou um fragmento de ligação ou cadeia(s) de imunoglobulina do mesmo, anticorpo, cadeia de imunoglobulina ou um fragmento de ligação do mesmo, composição, usos do anticorpo ou fragmento de ligação, de um antígeno, de um polinucleotídeo, de um vetor, ou de uma célula, e de uma molécula de ligação a antígeno tumoral, método para clonagem molecular de um anticorpo, e, kit para o diagnóstico de um tumor | |
| BR112014011331A2 (pt) | anticorpos específicos para trop-2 e seus usos | |
| EA201290570A1 (ru) | Конструкты, связывающиеся с ron, и способы их использования | |
| UA113609C2 (xx) | Антигензв'язуючий білок, який зв'язує людський il-23 | |
| ATE537188T1 (de) | Serumalbuminbindende proteine | |
| MX2010002269A (es) | Composiciones y metodos que comprenden proteinas de union para adalimumab. | |
| EA200702361A1 (ru) | АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ | |
| NO20084795L (no) | Fremgangsmate for a behandle, diagnostisere eller detektere kreft | |
| IL218442A0 (en) | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma | |
| ATE504602T1 (de) | Für humane matriptase spezifische bindungsproteine | |
| BR112012024997A2 (pt) | peptídeos ect2 e vacinas incluindo os mesmos | |
| BR112012022641A2 (pt) | peptídeos hjurp e vacinas que incluem os mesmos | |
| MY192517A (en) | Antibody specifically binding to pauf protein and use thereof | |
| WO2006133145A3 (en) | Tat-007 and methods of assessing and treating cancer | |
| WO2006116681A3 (en) | Tat-003 and methods of assessing and treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |